Within the URBC, under the direction of Professor Carine Michiels, several projects aim to better understand the factors contributing to the development of different types of tumors and the mechanisms that arise in response to treatment. Inès Bourriez focuses her research on skin cancers, which account for 40% of cancers diagnosed today. She is interested in the impact of skin aging and the accumulation of so-called senescent cells on tumor development and progression.
Understanding how cells react to radiation is also the focus of projects led by Emma Lambert, on the one hand, and Manon Van Den Abbeel, on the other, through a collaboration with Anne-Catherine Heuskin at LARN. Manon Van Den Abbeel is studying the irradiation conditions that induce the strongest possible immune response to circumvent the various immunosuppressive mechanisms developed within tumors, thereby enhancing the immunogenicity of tumors and thus their recognition and destruction by the immune system.
Emma Lambert, meanwhile, is launching a project on glioblastoma, an aggressive and currently incurable brain tumor, to better understand the resistance mechanisms that develop during combination treatments using chemotherapy, radiation therapy, or proton therapy.
As for Eloïse Rapport, she is interested in a third form of radiation therapy, using alpha particles—that is, ionized helium atoms—to increase the death of cancer cells within tumors. In particular, she is studying the different forms of induced cell death and their potential immunogenicity.